Outcome after brexu-cel infusion. Kaplan-Meier curve of survival probability and 95% confidence interval for EFS (A) and OS (B) in the infused cohort. OS according to prior HSCT (C), prior BLIN (D), response to brexu-cel (E), and pre-LD tumor burden (E). (G) Univariate analysis for EFS and OS. ECOG-PS, Eastern Cooperative Oncology Group performance status; NR, not reached.